David H. Adams, MD, is the Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai and the Cardiac Surgeon-in-Chief of the Mount Sinai Health System. He is also President of the Mitral Foundation, a not-for-profit organization dedicated to promoting best practice standards in mitral valve disease and supporting medical missions that advance the repair skills of surgeons in developing countries.
Dr. Adams is a recognized leader in the field of heart valve surgery and mitral valve reconstruction. From April 2018-May 2019, he served as the 99th President of the American Association for Thoracic Surgery, the world's oldest and most prestigious society dedicated to cardiothoracic surgery.
As the Program Director of the Mitral Valve Repair Center at the Mount Sinai Health System, he directs one of the largest programs in the United States. Dr. Adams and his team perform over 400 mitral valve operations per year while setting national benchmarks for clinical outcomes.
During his tenure at Mount Sinai, Dr. Adams co-authored the internationally acclaimed and widest selling valve textbook in history, Carpentier's Reconstructive Valve Surgery, with Professor Alain Carpentier,and also co-edited the benchmark reference textbook Cardiac Surgery in the Adult. He is the author of over 225 publications and is also an Associate Editor for Surgery for the Journal of the American College of Cardiologyand Associate Editor for Hurst’s the Heart, 14th edition. He has served on the Editorial Boards of several medical journals, including the Annals of Thoracic Surgery and Cardiology, and served as the co-Editor of Seminars in Thoracic and Cardiovascular Surgery.
He is the co-inventor of multiple mitral valve and tricuspid valve repair rings, including the Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring, the Carpentier-Edwards Physio II Annuloplasty Ring, is the inventor of the Medtronic Tri-Ad Adams Tricuspid Annuloplasty Ring, and holds three patents. He also currently serves as the National Co-Principal Investigator of multiple FDA pivotal randomized trials in the field of minimally invasive valve intervention, including the Medtronic CoreValve System for Transcatheter Aortic Valve Implantation, the Medtronic Intrepid System for Transcatheter Mitral Valve Replacement, and the NeoChord System for Surgical Mitral Valve Repair without cardiopulminary bypass.
Dr. Adams is an acclaimed speaker and educator. He is a co-director of the annual American College of Cardiology (ACC)/American Association for Thoracic Surgery (AATS) Heart Valve Summit, and the Director of the biennial AATS Mitral Conclave, the largest international meeting in the world focused on mitral valve disease. He has given over 350 invited lectures around the world and he and his team have developed the world’s largest video library of techniques in valve reconstruction. He is also dedicated to teaching surgery throughout the world, and he has performed surgery on over 200 patients in China, the Dominican Republic, Germany, Indonesia, Japan, Poland, Thailand, and Viet Nam.
Dr. Adams’ major research interests include outcomes related to mitral valve repair, strategies in complex mitral valve repair, and transcatheter valve replacement. Past research honors include the Alton Ochsner Research Scholarship from the American Association for Thoracic Surgery and the Paul Dudley White Research Fellowship from the American Heart Association. He has also received honorary Professorships from Capital University in Beijing and Keio University in Tokyo. He received his undergraduate and medical education at Duke University and completed his internship and residency in general and cardiothoracic surgery at Brigham and Women's Hospital and Harvard Medical School. In addition, he completed a two-year research fellowship under Professor Morris Karnovsky in the Department of Pathology at Harvard Medical School and an advanced cardiac surgical fellowship under Sir Magdi Yacoub in London. He later served at Brigham and Women's Hospital as the Associate Chief of Cardiac Surgery. He has held his current position as Professor and Chairman at the Icahn School of Medicine at Mount Sinai since 2002.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Adams during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Edwards Lifesciences
- Medtronic, Inc.
Dr. Adams is the co-inventor of the Edwards Lifesciences' Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring, the Carpentier-Edwards Physio II ring, and the Medtronic Tri-Ad Adams Tricuspid Annuloplasty Ring. The Icahn School of Medicine at Mount Sinai receives royalties from Edwards Lifesciences and Medtronic in connection with the sale of these products. Dr. Adams and Mount Sinai DO NOT receive any royalties when the devices are implanted in patients at Mount Sinai.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Schedule an Appointment or Ask a Question
Our recent paper in the Journal of the American College of Cardiology shows doctors with more experience provide patients better outcomes.
Sophie M. Connecticut
My number one piece of advice would be to research… with knowledge comes peace. ”Read Story
Reply: Off-Pump Surgeons' Experience Is Paramount to Delivering High-Quality CABG Outcomes: But What Constitutes Experience?Joanna Chikwe, MD, Timothy Lee, MD, Shinobu Itagaki, MD, David H. Adams, MD, Natalia N. Egorova, PhD
- Andrea Colli, MD, David Adams, MD, Alessandro Fiocco, MD, Nicola Pradegan, MD, Lorenzo Longinotti, MD, Matteo Nadali, MD, Dimosthenis Pandis, MD, Gino Gerosa, MD
Long-Term Outcomes After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting by Experienced Surgeons.Joanna Chikwe, MD, Timothy Lee, MD, Shinobu Itagaki, MD, David H. Adams, MD, Natalia N. Egorova, PhD
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.Thomas G. Gleason, MD, David H. Adams, MD, et al.